Ontology highlight
ABSTRACT: Purpose
TAK-831 is a highly selective and potent inhibitor of D-amino acid oxidase (DAAO) currently under clinical development for schizophrenia. In this study, a mechanistic multilayer quantitative model that parsimoniously connects pharmacokinetics (PK), target occupancy (TO) and D-serine concentrations as a pharmacodynamic (PD) readout was established in mice.Methods
PK, TO and PD time-profiles were obtained in mice and analyzed by mechanistic binding kinetics model connected with an indirect response model in a step wise fashion. Brain distribution was investigated to elucidate a possible mechanism driving the hysteresis between PK and TO.Results
The observed nonlinear PK/TO/PD relationship was well captured by mechanistic modeling framework within a wide dose r
SUBMITTER: Yoneyama T
PROVIDER: S-EPMC7478952 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature